Breakthrough: Russian Scientists Developed New Smart Material Based on Nanotechnology

A new material has been developed in Russia that will allow drugs to be transported to affected cells and will allow people to perform DNA testing at home.  The abstract has been published in ACS Publication titled “Nanoparticle Beacons: Supersensitive Smart Materials with On/Off-Switchable Affinity to Biomedical Targets.” The discovery was led by Maxim Nikitin from The Moscow Institute of Physics, and Technology (MIPT), known informally as PhysTech, a Russian university originally established in the Soviet Union. It prepares specialists in theoretical and applied physics, applied mathematics and related disciplines. MIPT is known for specifics of the MIPT educational process.

Strong Growth in Industrial Filtration Market

The industrial filtration market is expected to grow from an estimated $25.89 billion in 2018 to $35.47 billion by 2023, registering a CAGR of 6.50% during the forecast period. This growth is primarily due to the growing industrialization and urbanization, stringent regulations pertaining to emissions and treatment of industrial waste, and requirement of safe working environment in industrial facilities.

Therapeutic Monoclonal Antibodies Market Experiencing Significant Surge

Following the approval of the first monoclonal antibody in 1986, the approval and sales were flat until the introduction of the first chimeric monoclonal antibodies. Further approvals of humanized and fully human monoclonal antibodies, the market for therapeutic monoclonal antibodies experienced a significant surge to become a multi-billion dollar market in the current decade.

High Barrier Packaging Films for Pharmaceuticals Market: Increasing Preference for Unit Dosing, Smaller Pack Sizes

The demand for flexible packaging especially that made of biodegradable material is highly in demand today. People are preferring the use of sustainable products for packaging. The packaging industry is also witnessing the introduction of new and innovative packaging types for various applications in the food and pharmaceuticals industries.

Pick Up Over 8% Yield-to-Maturity with Mallinckrodt International, Bonds Mature April 2023

This week, Durig Capital looks to the healthcare sector where a specialty pharmaceutical company has posted solid back-to-back quarters resulting in increased guidance for 2018. As a result of Mallinckrodt Pharmaceuticals’ performance in both Q1 and Q2, company management has raised 2018 guidance citing solid performance across its product lines. Some of the highlights from Mallinckrodt’s Q2 numbers include:


  • Q2 cash flows from operating activities grew by 17.6% over the same period last year.

  • Net sales increased 5.3% year-over-year.

  • Adjusted Gross Profit increased by 8.4%

  • Year-to-date debt reduction of $535.2 million

  • Interest coverage over 2x for the first six months of 2018.